SIGA Pharmaceuticals, Inc.
Records under this name other than patents SIGA Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to SIGA Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,872,542 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria Lapsed on the fee record Ended Mar 29, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2013 | From the USPTO record |
| US 6,153,396 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria Formerly held Lapsed on the fee record Ended Nov 28, 2012 · From the USPTO record | Lapsed on the fee record | Ended Nov 28, 2012 | From the USPTO record |
| US 6,596,504 | Treatment of prophylaxis of diseases caused by pilus-forming bacteria Lapsed on the fee record Ended Jul 22, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jul 22, 2011 | From the USPTO record |
| US 6,548,265 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria Lapsed on the fee record Ended Apr 15, 2011 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2011 | From the USPTO record |
| US 6,420,127 | Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections Formerly held Lapsed on the fee record Ended Jul 16, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2010 | From the USPTO record |
| US 7,025,971 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria Lapsed on the fee record Ended Apr 11, 2010 · From the USPTO record | Lapsed on the fee record | Ended Apr 11, 2010 | From the USPTO record |
| US 6,962,791 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria Lapsed on the fee record Ended Nov 8, 2009 · From the USPTO record | Lapsed on the fee record | Ended Nov 8, 2009 | From the USPTO record |
| US 6,312,955 | Streptococcus gordonii strains resistant to fluorodeoxyuridine Lapsed on the fee record Ended Nov 6, 2009 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2009 | From the USPTO record |
| US 6,306,619 | DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function Lapsed on the fee record Ended Oct 23, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 23, 2009 | From the USPTO record |
| US 5,821,088 | Use of gram-positive bacteria to express recombinant proteins Formerly held Term ended Term ended no later than Oct 13, 2018 · Low confidence | Term ended | Term ended no later than Oct 13, 2018 | Low confidence |